Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000930413-02-000385
Filing Date
2002-02-13
Accepted
2002-02-13 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G c23193_sc13g.txt SC 13G 26020
  Complete submission text file 0000930413-02-000385.txt   28109
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 6194526600
LA JOLLA PHARMACEUTICAL CO (Subject) CIK: 0000920465 (see all company filings)

EIN.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-46742 | Film No.: 02542764
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address J.P. MORGAN PARTNERS 1221 AVENUE OF THE AMERICAS 40TH FLOOR NEW YORK NY 10020
Business Address J.P. MORGAN PARTNERS 1221 AVENUE OF THE AMERICAS 40TH FLOOR NEW YORK NY 10020 2128993400
JP MORGAN PARTNERS BHCA LP (Filed by) CIK: 0001106607 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231